Circulating Tumor DNA (ctDNA) is an Independent Predictor for Disease Recurrence Following Resection of Colorectal Liver Oligometastases

被引：0
|
作者：
Li, Shen [1 ]
Spurr, Liam [1 ]
Weichselbaum, Ralph [2 ]
Posner, Mitchell C. [1 ]
Pitroda, Sean [1 ]
机构：
[1] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[2] Univ Chicago, Chicago, IL 60637 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2024年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E233
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [31] Prediction model for detecting circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC).
    Pereira, Allan Andresson Lima
    Parikh, Aparna Raj
    Van Seventer, Emily E.
    Jia, Jingquan
    Loree, Jonathan M.
    Marie, Preeti Kanikarla
    Raghav, Kanwal Pratap Singh
    Morris, Van K.
    Overman, Michael J.
    Raymond, Victoria M.
    Lanman, Richard B.
    Talasaz, AmirAli
    Strickler, John H.
    Corcoran, Ryan Bruce
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Utility of Circulating Tumor DNA Assessment in Characterizing Recurrence Sites after Optimal Resection for Metastatic Colorectal Cancer
    Bansal, Varun V.
    Belmont, Erika
    Godley, Frederick
    Dhiman, Ankit
    Witmer, Hunter D.
    Li, Shen
    Liao, Andy
    Eng, Oliver S.
    Turaga, Kiran K.
    Shergill, Ardaman
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 238 (06) : 1013 - 1020
  • [33] Circulating Tumor DNA Predicts Recurrence after Hepatic Artery Infusion Chemotherapy for Colorectal Liver Metastases
    Cohen, Noah
    Khajoueinejad, Nazanin
    Tabrizian, Parissa
    Sarpel, Umut
    Golas, Benjamin J.
    Schwartz, Myron
    Labow, Daniel
    Hiotis, Spiros
    Ang, Celina
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S93 - S93
  • [34] A plasma-only integrated genomic and epigenomic circulating tumor DNA (ctDNA) assay to inform recurrence risk in colorectal cancer (CRC).
    Parikh, Aparna Raj
    Van Seventer, Emily E.
    Boland, Genevieve Marie
    Hartwig, Anna
    Jaimovich, Ariel
    Raymond, Victoria M.
    Talasaz, AmirAli
    Corcoran, Ryan Bruce
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] Circulating tumor DNA (ctDNA) testing for recurrence and treatment response monitoring in hepatocellular carcinoma (HCC)
    Abdelrahim, M.
    Mejia, A.
    Esmail, A.
    Ouf, M.
    Franses, J. W.
    Bhan, I.
    Sudha, K.
    Brdiges, C.
    Tin, T.
    Brewer, C.
    Aushev, V.
    Palsuledesai, C. C.
    Jurdi, A.
    Liu, M. C.
    Ghobrial, R. M.
    He, A. R.
    ANNALS OF ONCOLOGY, 2024, 35 : S82 - S82
  • [36] Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).
    Tie, Jeanne
    Kinde, Isaac
    Wang, Yuxuan
    Wong, Hui-li
    Skinner, Iain
    Wong, Rachel
    Steel, Malcolm
    Diaz, Luis A.
    Papadopoulos, Nickolas
    Kosmider, Suzanne
    Yip, Desmond
    Underhill, Craig
    Haydon, Andrew Mark
    Christie, Michael
    Strausberg, Robert
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Effect of dynamic circulating tumor DNA minimal residual disease detection on recurrence surveillance and second resection rate after curative intent resection of colorectal liver metastasis: A prospective cohort study.
    Li, Yaqi
    Xu, Jing
    Chen, Yikuan
    Ma, Xiaoji
    Hu, Xiang
    Chen, Yun
    Sun, Lei
    Wu, Huizi
    Xiu, Zhihui
    Dong, Qiduo
    Chen, Lin
    Liu, Jun
    Cai, Sanjun
    Peng, Junjie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 242 - 242
  • [38] Circulating tumor DNA (ctDNA) as a minimal residual disease (MRD) assessment and recurrence risk in patients undergoing curative intent resection with or without adjuvant chemotherapy in colorectal cancer: A systematic review and meta-analysis.
    Chidharla, Anusha
    Rapoport, Eliot
    Agarwal, Kriti
    Linares, Brenda
    Chakrabarti, Sakti
    Kasi, Anup
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] Survival and benefit of adjuvant chemotherapy (ACT) by circulating tumor DNA (ctDNA)-based genomic profile and molecular residual disease (MRD) in resectable colorectal oligometastases (CRM): PRECISION, a prospective multicenter study
    Kobayashi, S.
    Takamoto, T.
    Shiomi, A.
    Takahashi, A.
    Shiozawa, M.
    Shimizu, Y.
    Kagawa, Y.
    Nobuoka, D.
    Yamauchi, J.
    Kato, T.
    Oki, E.
    Taketomi, A.
    Takahashi, Y.
    Natsume, S.
    Niguma, T.
    Nakamura, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S428 - S429
  • [40] Heparanase expression predisposes to liver recurrence following resection of colorectal metastases
    Smith, AM
    Jayne, DG
    Fenwick, S
    Lodge, P
    Guillou, PJ
    BRITISH JOURNAL OF SURGERY, 2003, 90 (05) : 636 - 637
12345